BME:YMRE Statistics
Total Valuation
BME:YMRE has a market cap or net worth of EUR 98.10 million. The enterprise value is 196.22 million.
| Market Cap | 98.10M |
| Enterprise Value | 196.22M |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
BME:YMRE has 122.63 million shares outstanding.
| Current Share Class | 122.63M |
| Shares Outstanding | 122.63M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| Price/FFO Ratio | n/a |
| Price/AFFO Ratio | n/a |
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.73 |
| PB Ratio | 1.06 |
| P/TBV Ratio | 1.08 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -11.73 |
| EV / Sales | 7.46 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.70, with a Debt / Equity ratio of 1.08.
| Current Ratio | 1.70 |
| Quick Ratio | 0.63 |
| Debt / Equity | 1.08 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -0.66 |
Financial Efficiency
Return on equity (ROE) is -22.55% and return on invested capital (ROIC) is -1.69%.
| Return on Equity (ROE) | -22.55% |
| Return on Assets (ROA) | -1.50% |
| Return on Invested Capital (ROIC) | -1.69% |
| Return on Capital Employed (ROCE) | -2.44% |
| Revenue Per Employee | 13.16M |
| Profits Per Employee | -8.37M |
| Employee Count | 2 |
| Asset Turnover | 0.13 |
| Inventory Turnover | 0.82 |
Taxes
| Income Tax | -29,968 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -5.29% in the last 52 weeks. The beta is 0.28, so BME:YMRE's price volatility has been lower than the market average.
| Beta (5Y) | 0.28 |
| 52-Week Price Change | -5.29% |
| 50-Day Moving Average | 0.83 |
| 200-Day Moving Average | 0.85 |
| Relative Strength Index (RSI) | n/a |
| Average Volume (20 Days) | 1,630 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BME:YMRE had revenue of EUR 26.32 million and -16.73 million in losses.
| Revenue | 26.32M |
| Gross Profit | 4.99M |
| Operating Income | -4.92M |
| Pretax Income | -17.42M |
| Net Income | -16.73M |
| EBITDA | -529,688 |
| EBIT | -4.92M |
| Earnings Per Share (EPS) | n/a |
Balance Sheet
The company has 3.80 million in cash and 100.15 million in debt, giving a net cash position of -96.35 million or -0.79 per share.
| Cash & Cash Equivalents | 3.80M |
| Total Debt | 100.15M |
| Net Cash | -96.35M |
| Net Cash Per Share | -0.79 |
| Equity (Book Value) | 92.79M |
| Book Value Per Share | n/a |
| Working Capital | 12.95M |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 18.94%, with operating and profit margins of -18.71% and -63.58%.
| Gross Margin | 18.94% |
| Operating Margin | -18.71% |
| Pretax Margin | -66.18% |
| Profit Margin | -63.58% |
| EBITDA Margin | -2.01% |
| EBIT Margin | -18.71% |
| FCF Margin | n/a |
Dividends & Yields
BME:YMRE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -17.06% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |